fbpx

US lifts pause on Johnson & Johnson vaccine

US health regulators have lifted an 11-day pause on the Johnson & Johnson (J&J) Covid-19 jab, but will add a warning label about the potential for extremely rare blood clots.

A Centers for Disease Control and Prevention (CDC) panel earlier approved restarting US rollout of the shot.

Fifteen vaccine recipients suffered from a dangerous blood clot out of nearly eight million given the jab.

This week, Europe’s drug regulator also ended restrictions on the J&J vaccine.

European regulators this month also linked similar, highly unusual blood clots to the AstraZeneca Covid-19 shot, but found the benefits of the drug outweighed any risks.

Read the full article at: BBC

TOP